156
Participants
Start Date
May 25, 2016
Primary Completion Date
March 31, 2027
Study Completion Date
March 31, 2027
Systemic therapy
Systemic therapy is selected by the physician and is not restricted by the study. Molecular testing will be performed on tissue and blood to identify patterns and relationships with clinical outcomes in each group.
StrataNGS
CLIA-approved assay that is being performed as part of standard of care genomic profiling of patients tumor biopsies. The product currently covers about 90 cancer genes and is able to pick up all the known mutations and other types of genetic alterations across them, he added
University of California, San Francisco, San Francisco
Collaborators (1)
Prostate Cancer Foundation
OTHER
Strata Oncology
INDUSTRY
University of California, San Francisco
OTHER